Your browser doesn't support javascript.
loading
De novo natural anti-M alloantibody emergence in severe Coronavirus Disease 2019.
Jeannet, Robin; Descazeaud, Alexandra; Daix, Thomas; Pauthier, Hélène; Pascal, Virginie; Hantz, Sébastien; Cam, Sophie Le; Francois, Bruno; Feuillard, Jean; Lafarge, Xavier.
Afiliación
  • Jeannet R; INSERM CIC 1435, CHU Dupuytren, and UMR CNRS 7276 INSERM 1262, Université de Limoges, Limoges, France. Electronic address: Robin.jeannet@unilim.fr.
  • Descazeaud A; Laboratoire d'Immunohématologie, Établissement Français du Sang Nouvelle-Aquitaine, Limoges, France. Electronic address: Alexandra.Descazeaud@efs.sante.fr.
  • Daix T; INSERM CIC 1435 and Réanimation polyvalente, CHU Dupuytren, and INSERM UMR 1092, Université de Limoges, Limoges, France. Electronic address: thomas.daix@chu-limoges.fr.
  • Pauthier H; Laboratoire d'Immunohématologie, Établissement Français du Sang Nouvelle-Aquitaine, Limoges, France. Electronic address: Helene.Pauthier@efs.sante.fr.
  • Pascal V; UMR CNRS 7276, INSERM 1262, Université de Limoges, and Laboratoire d'Immunologie, CHU Dupuytren, Limoges, France. Electronic address: Virginie.PASCAL@chu-limoges.fr.
  • Hantz S; UMR INSERM 1092, RESINFIT, Université de Limoges, and Centre National de Référence des Herpèsvirus and Service de Bactériologie, Virologie et Hygiène, CHU Dupuytren, Limoges, France. Electronic address: Sebastien.Hantz@chu-limoges.fr.
  • Cam SL; Laboratoire de qualification biologique des dons, Établissement Français du Sang Centre-Pays de la Loire, Angers, France. Electronic address: sophie.lecam@efs.sante.fr.
  • Francois B; INSERM CIC 1435 and Réanimation polyvalente, CHU Dupuytren, and INSERM UMR 1092, Université de Limoges, Limoges, France. Electronic address: b.francois@unilim.fr.
  • Feuillard J; UMR CNRS 7276 / INSERM 1262 CRIBL and Laboratoire d'Hématologie, Faculté de Médecine and CHU Dupuytren, Limoges, France. Electronic address: jean.feuillard@unilim.fr.
  • Lafarge X; INSERM U1035 Biothérapie des Maladies Génétiques, Inflammatoires et Cancers, and Direction Médicale, Établissement Français du Sang Nouvelle-Aquitaine, Bordeaux, France. Electronic address: xavier.lafarge@efs.sante.fr.
J Infect Public Health ; 15(12): 1455-1458, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36403401
ABSTRACT
The immune response is a key player in the course of SARS-CoV-2 infection, and is often seriously dysfunctional in severe Coronavirus Disease 2019. The hyperinflammatory status has been described to be accompanied by the appearance of autoantibodies. In a lethal COVID-19 infection, we observed the emergence of a de novo natural alloantibody which targeted the M antigen from the MNS blood group on red blood cells (RBC) without evidence of any cross-reaction with SARS-CoV-2 antigens. This IgM lambda alloantibody was unmutated and unswitched. Here, we describe for the first time the emergence of a bystander de novo natural alloantibody against RBCs in a severe COVID-19 patient, highlighting the extra-follicular humoral response reported in these cases.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Grupos Sanguíneos / COVID-19 Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article